168 related articles for article (PubMed ID: 24767830)
1. Successful treatment of juvenile xanthogranuloma using bevacizumab.
Ashkenazy N; Henry CR; Abbey AM; McKeown CA; Berrocal AM; Murray TG
J AAPOS; 2014 Jun; 18(3):295-7. PubMed ID: 24767830
[TBL] [Abstract][Full Text] [Related]
2. Optical coherence tomography characteristics of epi-iridic membrane in a child with recurrent hyphema and presumed juvenile xanthogranuloma.
Manjandavida FP; Arepalli S; Tarlan B; Shields CL
J AAPOS; 2014 Feb; 18(1):93-5. PubMed ID: 24568997
[TBL] [Abstract][Full Text] [Related]
3. Combined therapy with intravitreal bevacizumab and posterior subtenon triamcinolone acetonide injection in diabetic macular oedema.
Kim HD; Kang KD; Choi KS; Rhee MR; Lee SJ
Acta Ophthalmol; 2014 Nov; 92(7):e589-90. PubMed ID: 24866832
[No Abstract] [Full Text] [Related]
4. Benefit from bevacizumab for macular edema in central retinal vein occlusion: twelve-month results of a prospective, randomized study.
Epstein DL; Algvere PV; von Wendt G; Seregard S; Kvanta A
Ophthalmology; 2012 Dec; 119(12):2587-91. PubMed ID: 22902212
[TBL] [Abstract][Full Text] [Related]
5. Juvenile Xanthogranuloma Involving the Eye and Ocular Adnexa: Tumor Control, Visual Outcomes, and Globe Salvage in 30 Patients.
Samara WA; Khoo CT; Say EA; Saktanasate J; Eagle RC; Shields JA; Shields CL
Ophthalmology; 2015 Oct; 122(10):2130-8. PubMed ID: 26189188
[TBL] [Abstract][Full Text] [Related]
6. Subconjunctival steroid in the management of uveal juvenile xanthogranuloma: a case report.
Treacy KW; Letson RD; Summers CG
J Pediatr Ophthalmol Strabismus; 1990; 27(3):126-8. PubMed ID: 2114475
[TBL] [Abstract][Full Text] [Related]
7. Three-year visual outcome of photodynamic therapy plus intravitreal bevacizumab with or without subtenon triamcinolone acetonide injections for polypoidal choroidal vasculopathy.
Sakai T; Ohkuma Y; Kohno H; Hayashi T; Watanabe A; Tsuneoka H
Br J Ophthalmol; 2014 Dec; 98(12):1642-8. PubMed ID: 25053762
[TBL] [Abstract][Full Text] [Related]
8. Effect of combination therapy with bevacizumab and dexamethasone intravitreal implant in patients with retinal vein occlusion.
Singer MA; Bell DJ; Woods P; Pollard J; Boord T; Herro A; Porbandarwalla S
Retina; 2012 Jul; 32(7):1289-94. PubMed ID: 22466480
[TBL] [Abstract][Full Text] [Related]
9. Intravitreal bevacizumab for the treatment of choroidal metastasis.
Kim M; Kim CH; Koh HJ; Lee SC; Kim SS
Acta Ophthalmol; 2014 Feb; 92(1):e80-2. PubMed ID: 24165227
[No Abstract] [Full Text] [Related]
10. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
Ding X; Li J; Hu X; Yu S; Pan J; Tang S
Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
[TBL] [Abstract][Full Text] [Related]
11. Glaucoma in juvenile xanthogranuloma.
Vendal Z; Walton D; Chen T
Semin Ophthalmol; 2006; 21(3):191-4. PubMed ID: 16912017
[TBL] [Abstract][Full Text] [Related]
12. Moment of cyst eruption captured by optical coherence tomography in diabetic macular edema.
Oh JH; Oh J
Retina; 2015 Jun; 35(6):1283-4. PubMed ID: 25621946
[No Abstract] [Full Text] [Related]
13. Intravitreal bevacizumab for previously treated choroidal neovascularization from age-related macular degeneration.
Goff MJ; Johnson RN; McDonald HR; Ai E; Jumper JM; Fu A
Retina; 2007; 27(4):432-8. PubMed ID: 17420694
[TBL] [Abstract][Full Text] [Related]
14. Intravitreal triamcinolone acetonide versus combined intravitreal bevacizumab and dexamethasone in diffuse diabetic macular oedema.
Sheth S; Rush R; Natarajan S; Gillies M
Clin Exp Ophthalmol; 2011; 39(7):673-81. PubMed ID: 22452685
[TBL] [Abstract][Full Text] [Related]
15. Treatment of ocular metastasis with anti-VEGF: a literature review and case report.
Augustine H; Munro M; Adatia F; Webster M; Fielden M
Can J Ophthalmol; 2014 Oct; 49(5):458-63. PubMed ID: 25284103
[TBL] [Abstract][Full Text] [Related]
16. Complete resolution of iris juvenile xanthogranuloma in an infant with topical corticosteroid treatment only.
Winter AW; Lyons CJ
Can J Ophthalmol; 2022 Feb; 57(1):e10-e11. PubMed ID: 34077746
[No Abstract] [Full Text] [Related]
17. Intravitreal bevacizumab for retinal capillary hemangioblastoma: A case series and literature review.
Slim E; Antoun J; Kourie HR; Schakkal A; Cherfan G
Can J Ophthalmol; 2014 Oct; 49(5):450-7. PubMed ID: 25284102
[TBL] [Abstract][Full Text] [Related]
18. Expression of vascular endothelial growth factor and intravitreal anti-VEGF therapy with bevacizumab in vasoproliferative retinal tumors.
Saito W; Kase S; Fujiya A; Dong Z; Noda K; Ishida S
Retina; 2013 Oct; 33(9):1959-67. PubMed ID: 23652580
[TBL] [Abstract][Full Text] [Related]
19. Fluorescein angiography of iris juvenile xanthogranuloma.
Danzig CJ; Shields CL; Mashayekhi A; Ehya H; Manquez ME; Shields JA
J Pediatr Ophthalmol Strabismus; 2008; 45(2):110-2. PubMed ID: 18404959
[TBL] [Abstract][Full Text] [Related]
20. Response to aflibercept as secondary therapy in patients with persistent retinal edema due to central retinal vein occlusion initially treated with bevacizumab or ranibizumab.
Eadie JA; Ip MS; Kulkarni AD
Retina; 2014 Dec; 34(12):2439-43. PubMed ID: 24999721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
